Skip To Main Content
Susheng Shi on Muck Rack

Susheng Shi

As seen in: Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Susheng

Contact Susheng, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy and Safety of Anthracyclines Combined with Temozolomide Regimens for the Treatment of Advanced Leiomyosarcoma: A Retrospective Study

|
By Huijing Tan, Jianguo Zhou, Susheng Shi
| Dove Medical Press
Back to Journals » Therapeutics and Clinical Risk Management » Volume 22 Authors Tan H, Zhou J, Shi S , Jiang L, Zuo L, Su A, Wang H , Sun Y, Xuan W, Chi Y Received 30 August 2025 Accepted for publication 6 April 2026 Published 15 April 2026 Volume 2026:22 564176 DOI https://doi.org/10.2147/TCRM.S564176 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Professor De Yun Wang Huijing Tan,1 Jianguo Zhou,2 Susheng Shi,3...
Open in Who Shared Issue with article?

Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma

|
By Yue Stella Yu Verified, Xuejiao Shi, Mei Luo, Zhirong Zhang, Susheng Shi
| PLOS
Ten-eleven translocation (TET) enzymes catalyze the oxidation of 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC), 5-formylcytosine and 5-carboxylcytosine, which result in genomic DNA demethylation. It was reported that 5-hmC levels were decreased in a variety of cancers and could be regarded as an epigenetic hallmark of cancer.
Open in Who Shared Issue with article?
See all 2 articles